Novel next-generation Bruton tyrosine kinase (BTK)-targeted protein degrader APG-3288 has received investigational new drug (IND) clearance from the U.S. FDA, marking another major expansion to the co ...
In October 2025, Case Comprehensive Cancer Center announced a clinical trial is to see if shorter Photodynamic Therapy (PDT) ...
A study published in the International Journal of Molecular Sciences reports that a cannabis extract reduced cell growth, ...